Lv45
477 积分 2025-11-19 加入
你好，陌生人
Alpha-MnO2 catalyst with high formaldehyde oxidation and moisture resistance by joint cerium modification and phosphoric acid post-treatment
10天前
已完结
Efficient MnOx-Co3O4-CeO2 catalysts for formaldehyde elimination
10天前
已完结
Electrospun SiO2 aerogel/polyacrylonitrile composited nanofibers with enhanced adsorption performance of volatile organic compounds
11天前
已完结
Reinforced resorcinol formaldehyde aerogel with Co-assembled polyacrylonitrile nanofibers and graphene oxide nanosheets
11天前
已完结
Efficient formaldehyde removal by maximizing adsorption/catalytic sites over graphene-Ce modified TiO2
13天前
已完结
Efficient HCHO oxidation at room temperature via maximizing catalytic sites in 2D coralloid δ-MnO2@GO
13天前
已完结
Lotus seedpods-inspired, highly efficient and durable Ce-doped modified manganese-based catalysts for enhanced formaldehyde removal at room temperature
13天前
已完结
Catalytic oxidization of indoor formaldehyde at room temperature – Effect of operation conditions
13天前
已完结
Fabrication of Ag@Ag2O-MnOx composite nanowires for high-efficient room-temperature removal of formaldehyde
13天前
已完结
A photothermal cellulose-based material for rapid anti-bacteria and HCHO removal via sequential formation of MnO2 coatings and amine-quinone networks
14天前
已完结
Non-stoichiometric Mg-Ni composites for hydrogen storage: role of in-situ Mg2Ni formation in enhancing hydrogen sorption performance
2天前
已采纳
Degradation of polyester polyurethane by a newly isolated soil bacterium, Bacillus subtilis strain MZA-75
2天前
已采纳
CMAS/cyclic molten salt corrosion - resistant potential of Nb2O5-doped YTaO4 for thermal barrier coatings
5个月前
已采纳
Construction of Functional Metal-Organic Frameworks and Their Applications in the Biomedical Field
5个月前
已采纳
On the Crystal Structure of Poly(α-benzyl γ,dl-glutamate) of Microbial Origin
5个月前
已采纳
Surveillance for Hepatocellular Carcinoma: Can We Focus on the Mission?
5个月前
已采纳
基于群组轨迹模型的肺癌患者围手术期症状异质性研究
5个月前
已采纳
Tips of family history taking in diagnosing Alport syndrome: a report of six cases
5个月前
已采纳
633P Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase III ARAMIS trial
5个月前
已采纳
皖公网安备34019202002308
